Europe Molecular Diagnostic Analyzers and Reagent Forecasts for 100 Tests: A 31-Country Analysis Including France, Italy & Spain - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Oct 11, 2019--
The “Europe Molecular Diagnostic Analyzers and Reagent Forecasts for 100 Tests: A 31-Country Analysis-Infectious and Genetic Diseases, Cancer, Forensic and Paternity Testing-Supplier Shares, Emerging Technologies, Instrumentation Review, Opportunities” report has been added to ResearchAndMarkets.com’s offering.
This new 31-country report from the author is available by country, market segment, section, or individual test.
The report is designed to help current suppliers and potential market entrants identify and evaluate major business opportunities emerging in the molecular diagnostics market during the next five years.
The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods.
In order to successfully capitalize on the opportunities presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostic companies during the next five years.
Austria, Belgium, Bulgaria, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Malta, Netherlands, Norway, Poland, Portugal, Romania, Serbia, Slovakia, Slovenia, Spain, Sweden, Switzerland, UK
Market Segmentation Analysis
Opportunities and Strategic Recommendations
For more information about this report visit https://www.researchandmarkets.com/r/fawzgm
View source version on businesswire.com:https://www.businesswire.com/news/home/20191011005253/en/
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
INDUSTRY KEYWORD: HEALTH GENETICS
SOURCE: Research and Markets
Copyright Business Wire 2019.
PUB: 10/11/2019 07:54 AM/DISC: 10/11/2019 07:54 AM